British Thoracic Society Paediatric Pneumonia Audit: a review of 3 years of data

Related Experiment Video

Updated: May 15, 2026

International Expert Consensus and Recommendations for Neonatal Pneumothorax Ultrasound Diagnosis and Ultrasound-guided Thoracentesis Procedure
05:50

International Expert Consensus and Recommendations for Neonatal Pneumothorax Ultrasound Diagnosis and Ultrasound-guided Thoracentesis Procedure

Published on: March 12, 2020

Sarah-Jane M Bowen1, Anne H Thomson

  • 1Department of Paediatric Respiratory Medicine, Oxford Children's Hospital, Oxford University Hospitals NHS Trust, Oxford, UK.

Thorax
|January 8, 2013
PubMed

Insights

This study found that community-acquired pneumonia (CAP) management in children often overuses investigations and underuses oral antibiotics like amoxicillin. Adhering to British Thoracic Society (BTS) guidelines can improve care and conserve resources.

Area of Science:

  • Pediatric respiratory medicine
  • Clinical audit and quality improvement
  • Infectious disease management

Background:

  • The British Thoracic Society (BTS) developed guidelines for managing community-acquired pneumonia (CAP) in children.
  • These guidelines serve as the standard for the annual BTS Paediatric Pneumonia Audit.

Purpose of the Study:

  • To examine 3 years of data from the BTS Paediatric Pneumonia Audit.
  • To identify trends in clinical practice for pediatric CAP.
  • To assess the impact of the 2011 BTS guideline revisions on CAP management.

Main Methods:

  • Analysis of national audit data spanning three years.
  • Evaluation of clinical practice trends in pediatric CAP management.
  • Assessment of adherence to BTS guidelines.

Main Results:

  • Over-reliance on diagnostic investigations for pneumonia.
  • Underuse of oral antibiotics, specifically amoxicillin.
  • Inappropriate utilization of chest physiotherapy, outpatient appointments, and repeat chest X-rays.

Conclusions:

  • Current clinical practices for pediatric CAP show deviations from BTS guidelines.
  • Improved adherence to BTS guidelines can enhance patient care.
  • Optimizing guideline adherence can lead to significant savings in secondary care resources.

Keywords:
Pneumonia

More Related Videos

Use of Artificial Sputum Medium to Test Antibiotic Efficacy Against Pseudomonas aeruginosa in Conditions More Relevant to the Cystic Fibrosis Lung07:46

Use of Artificial Sputum Medium to Test Antibiotic Efficacy Against Pseudomonas aeruginosa in Conditions More Relevant to the Cystic Fibrosis Lung

Published on: June 5, 2012

Related Concept Videos

Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumothorax-II01:27

Pneumothorax-II

Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories: